AFFILIATES TRANSACTIONS

12 Months Ended

Dec. 31, 2023

Related Party Transactions [Abstract]

AFFILIATES TRANSACTIONS

NOTE 5 - AFFILIATES TRANSACTIONS

The Company hold License Agreements (the “License/s” or “Agreement/s”) for a medical device (license obtained in 2019) and a compound (license obtained in 2021), with two affiliated companies where in the officers of the Company hold a majority interest. The products were developed prior to the establishment of Bioxytran. The maintenance cost for each license amounts to $5,000 yearly. In 2022, the Company also reimbursed the affiliates for the legal and administrative costs surrounding the establishment of the Licenses for a total amount of $34,220.